Name: Latest research reports of Saatvik Green Energy Ltd. authored by Deven Choksey and published by - Trendlyne research reports.
Item: Saatvik Green Energy Ltd.
Rating: 5
Author: Deven Choksey

Saatvik Green Energy Ltd.

18 Sep 2025

438.20

-1.97%

IPO Note

IPO Subscribe: Saatvik Green Energy Ltd.

Deven Choksey

Since inception the Company has delivered over 2.5 GW of module to domestic and international customers. It deploys range of technologies to fulfill diverse consumer needs, through a distribution network of 53 selling partners, including 23 resellers, 19 distributors and 11 channel partners.

Deven Choksey released a IPO Subscribe report for Saatvik Green Energy Ltd. on 18 Sep, 2025.

Nifty 50

18 Sep 2025

24611.10

-0.10%

BAZAAR PULSE

Nifty 50

invest4Edu

MARKET SNAPSHOT

Nifty 50 is trading below its 30 day SMA of 24911.0

Bank Nifty

18 Sep 2025

54635.85

0.32%

DAILY MARKET MIRROR

Bank Nifty

SBI Securities

END OF DAY SUMMARY

SBI Securities released a Daily Note report for Bank Nifty on 30 Sep, 2025.

Nifty 50

18 Sep 2025

24611.10

-0.10%

Daily Derivative Report

Nifty 50

SBI Securities

Retail Research

Nifty 50 is trading above its 200 day SMA of 24162.0

GK Energy Ltd.

17 Sep 2025

162.10

-1.43%

GK Energy Ltd IPO Note

IPO Subscribe: GK Energy Ltd.

SBI Securities

company offers farmers an end-to-end single source solution for the survey, design, supply, assembly and installation, testing, commissioning and maintenance of solar-powered pump systems. The company is an empaneled vendor under the PM-KUSUM scheme in the states of Maharashtra, Haryana, Rajasthan, Uttar Pradesh and Madhya Pradesh with Maharashtra accounting for over 95% of SPPS installed by the company in F25. The company currently operates an asset-light model wherein it sources solar panels, pumps and various other components from different specialised vendors. Going forward,...

No SMAs available

Ivalue Infosolutions Ltd.

17 Sep 2025

279.00

-2.31%

IVALUE

IPO Subscribe: Ivalue Infosolutions Ltd.

Hem Securities

Company is an enterprise technology solutions specialist based out of India, offering comprehensive, purpose-built solutions for securing and managing digital applications and data. Company primarily serve large enterprises in their digital transformation by understanding their needs and working with System Integrators and OEMs to identify, recommend and deploy solutions meeting their requirements, aimed at ensuring performance, availability, scalability and security of digital applications and data. As per...

No SMAs available

Aditya Birla Capital Ltd.

17 Sep 2025

292.35

0.86%

Driving growth and stability through retail acceleration

Buy: Aditya Birla Capital Ltd.

Target

Motilal Oswal

Aditya Birla Capital (ABCL) has steadily evolved into a digitally enabled, customer-focused financial services platform with a diversified presence spanning lending, insurance, and asset management.

Aditya Birla Capital Ltd. is trading above all available SMAs

Natco Pharma Ltd.

17 Sep 2025

795.55

0.02%

NATCO PHARMA

Hold: Natco Pharma Ltd.

Target

Geojit BNP Paribas

The management maintains a long-term perspective on the business, aiming to navigate potential challenges and seize growth opportunities. We anticipate a steep revenue degrowth because of lower Revlimid sales in FY27. Focus will shift on the domestic formulations business with the anticipated launches of Semaglutide, which strengthens our case for...

Number of MF schemes decreased from 54 to 47 in Jun 2025 qtr

The Ramco Cements Ltd.

17 Sep 2025

985.40

-1.15%

RAMCO CEMENTS LIMITED

Accumulate: The Ramco Cements Ltd.

Recommendation Target

Geojit BNP Paribas

Kolimigundla, debottlenecking of existing plants, and additional grinding capacities. We value TRCL at 15x FY27E EV/EBITDA (vs. 3-year average of ~14x), arriving at a target price of 1,270, and downgrade the rating to Accumulate....

The Ramco Cements Ltd. is trading below all available SMAs

Abbott India Ltd.

17 Sep 2025

29290.00

-1.26%

Steady business, outpacing Pharma peers

Buy: Abbott India Ltd.

Target

Sharekhan

Strong history of product launches: Abbott India has been steadily growing led by consistent launches of both - own and Novo Nordisk’s products (marketing). Abbott India has launched over 100 products in India in the last 12 years and we expect the pipeline to stay strong.

Abbott India Ltd. is trading below all available SMAs